Filing Details

Accession Number:
0001209191-23-055083
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-13 19:11:13
Reporting Period:
2023-11-13
Accepted Time:
2023-11-13 19:11:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1817713 Janux Therapeutics Inc. JANX () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1652901 Avalon Ventures Xi, L.p. 1134 Kline Street
La Jolla CA 92037
No No Yes No
1844550 Avalon Bioventures Spv I, L.p. 1134 Kline Street
La Jolla CA 92037
No No Yes No
1873935 Avalon Bioventures I, Lp 1134 Kline Street
La Jolla CA 92037
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-11-13 849,854 $5.87 849,854 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,387,217 Direct
Common Stock 4,479,492 Indirect See footnote
Footnotes
  1. The shares are directly held by Avalon BioVentures I, LP (ABV I). Avalon BioVentures GP, LLC is a general partner of ABV I and may be deemed to have voting and investment power with respect to the shares held by ABV I and as a result may be deemed to have beneficial ownership of such shares. Jay B. Lichter, Tighe M. Reardon, Sanford J. Madigan and Sergio G. Duron share voting and investment power with respect to the shares held by ABV I. Each of such individuals disclaims beneficial ownership of all shares held by ABV I except to the extent of each such individual's actual pecuniary interest therein, if any.
  2. The shares are directly held by Avalon Ventures XI, L.P. (Avalon Ventures). Avalon Ventures XI GP LLC (Avalon XI GP) is general partner of Avalon Ventures and may be deemed to have voting and investment power with respect to the shares held by Avalon Ventures. Kevin Kinsella, Richard Levandov, Braden Bohrmann and Jay B. Lichter are managing members of Avalon XI GP. Mr. Kinsella, Mr. Levandov, Mr. Bohrmann and Dr. Lichter share voting and investment power with respect to the shares held by Avalon Ventures. Each of such individuals disclaims beneficial ownership of all shares held by Avalon Ventures except to the extent of each such individual's actual pecuniary interest therein, if any.
  3. The shares are directly held by Avalon BioVentures SPV I, LP (ABV SPV). ABV SPV I GP LLC (ABV GP) is a general partner of ABV SPV and may be deemed to have voting and investment power with respect to the shares held by ABV SPV and as a result may be deemed to have beneficial ownership of such shares. Jay Lichter and Tighe Reardon share voting and investment power with respect to the shares held by ABV SPV. Each of such individuals disclaims beneficial ownership of all shares held by ABV SPV except to the extent of each such individual's actual pecuniary interest therein, if any.